Summit Securities Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
Summit Securities Group's ZBH Position: Q2 2026 in Review
Summit Securities Group increased its Zimmer Biomet (ZBH) stake by 133% in Q2 2026, buying an estimated $81.3K and bringing the position to 1,622 shares worth $140K. The position accounts for 0.01% of the portfolio, ranked #323.
Summit Securities Group first reported a position in ZBH in Q3 2013 and has held it in 13 quarters since. The position peaked at $296K in Q1 2017. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Summit Securities Group held 1,622 shares of Zimmer Biomet worth $140K as of Q2 2026.
- Summit Securities Group bought 927 Zimmer Biomet shares in Q2 2026, an estimated $81.3K.
- Zimmer Biomet made up 0.01% of Summit Securities Group's portfolio in Q2 2026, its #323 holding.
- Summit Securities Group first reported a position in Zimmer Biomet in Q3 2013 and has held it in 13 quarters since.
- Summit Securities Group's Zimmer Biomet position peaked at $296K in Q1 2017.
- 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.